Tag: OxyContin

Drug Enforcement Administration Issues First Public Safety Alert in over Half a Decade After Surges in Illicit Fentanyl

Michigan Star Staff
Fentanyl

The Drug Enforcement Administration (DEA) issued a Public Safety Alert Monday warning of the surge in illegal fake painkillers combined with illicit fentanyl or methamphetamine.

The Public Safety Alert, the first warning in six years, highlighted the surge in fentanyl and methamphetamine-laced pills mass produced by criminal drug groups, which are killing Americans at a historic rate, according to a DEA press release.

“The United States is facing an unprecedented crisis of overdose deaths fueled by illegally manufactured fentanyl and methamphetamine,” Anne Milgram, administrator of the DEA, said in the press release.

Read More

Former Head of OxyContin Giant Purdue Pharma Denies Fault or Blame in Opioid Crisis

Michigan Star Staff

The former president and board chair of Purdue Pharma testified in court on Wednesday that he, his family and the company are not at fault for the opioid crisis, CBS News reported.

Richard Sackler, 76, who is a member of the family that owns the OxyContin maker, denied responsibility at a White Plains, New York, bankruptcy hearing, CBS News reported.

Read More

OxyContin Maker Purdue Pharma to Plead to Three Criminal Charges

The Associated Press

Purdue Pharma, the company that makes OxyContin, the powerful prescription painkiller that experts say helped touch off an opioid epidemic, will plead guilty to three federal criminal charges as part of a settlement of more than $8 billion, Justice Department officials announced Wednesday.

The company will plead guilty to three counts, including conspiracy to defraud the United States and violating federal anti-kickback laws, the officials said. The resolution will be detailed in a bankruptcy court filing in federal court.

Read More

Experts: Revamped OxyContin Hasn’t Curbed Abuse, Overdoses

The Associated Press

A panel of government health advisers said Friday there’s no clear evidence that a harder-to-crush version of the painkiller OxyContin designed to discourage abuse actually resulted in fewer overdoses or deaths.

The conclusion from the Food and Drug Administration advisory panel comes more than a decade after Purdue Pharma revamped its blockbuster opioid, which has long been blamed for sparking a surge in painkiller abuse beginning in the 1990s.

Read More